Insmed
INSM
#730
Rank
โ‚น3.065 T
Marketcap
โ‚น14,376
Share price
-0.60%
Change (1 day)
113.26%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -โ‚น95.42 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น0.44 Billion. In 2024 the company made an earning of -โ‚น76.05 Billion a decrease over its 2023 earnings that were of -โ‚น61.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น95.42 Billion25.48%
2024 -โ‚น76.05 Billion23.71%
2023 -โ‚น61.47 Billion45.77%
2022 -โ‚น42.17 Billion15.83%
2021 -โ‚น36.41 Billion50.19%
2020 -โ‚น24.25 Billion16.4%
2019 -โ‚น20.83 Billion-23.9%
2018 -โ‚น27.37 Billion59.35%
2017 -โ‚น17.18 Billion8.52%
2016 -โ‚น15.83 Billion47.25%
2015 -โ‚น10.75 Billion34.53%
2014 -โ‚น7.99 Billion58.83%
2013 -โ‚น5.03 Billion35.14%
2012 -โ‚น3.73 Billion-31.92%
2011 -โ‚น5.47 Billion854.92%
2010 -โ‚น0.58 Billion-105.22%
2009 โ‚น10.96 B-905.06%
2008 -โ‚น1.37 Billion-27.31%
2007 -โ‚น1.88 Billion-62.41%
2006 -โ‚น4.99 Billion98.19%
2005 -โ‚น2.52 Billion0.03%
2004 -โ‚น2.52 Billion159.07%
2003 -โ‚น0.98 Billion-69.31%
2002 -โ‚น3.17 Billion
2000 -โ‚น2.85 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.504 T-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น905.96 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น408.85 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น23.12 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.13 Billion-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น0.40 B-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA